A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. | Arthritis Rheum;44(6): 1351-8, 2001 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.

Pope, J E; Bellamy, N; Seibold, J R; Baron, M; Ellman, M; Carette, S; Smith, C D; Chalmers, I M; Hong, P; O'Hanlon, D; Kaminska, E; Markland, J; Sibley, J; Catoggio, L; Furst, D E.

Affiliation

Pope JE; University of Western Ontario, London, Canada.

Arthritis Rheum ; 44(6): 1351-8, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11407694

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Methotrexate / Immunosuppressive Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2001 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Methotrexate / Immunosuppressive Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2001 Document type: Article Affiliation country: